Home › Membranous Glomerulonephritis › Pennsylvania
Membranous Glomerulonephritis clinical trials in Pennsylvania
3 studies for Membranous Glomerulonephritis are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Belimumab With Rituximab for Primary Membranous Nephropathy
- University of Pennsylvania: Department of Medicine: Renal-Electrolyte and Hypertension Division, Philadelphia
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT03949855NEPTUNE Match Study
- Hospital of the University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.